Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis
PolandStudy of N-Acetyl-GED-0507-34-LEVO 5% gel applied daily for 12 weeks in patients with acne vulgaris
PolandStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
PolandStudy on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer's Disease
PolandTitle: Long-term safety study of N-Acetyl-GED-0507-34-LEVO gel 5% applied to the skin for patients with acne vulgaris
PolandStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
PolandStudy on Obinutuzumab and Rituximab with Chemotherapy for Adults with Newly Diagnosed CD20-Positive Acute Lymphoblastic Leukemia
PolandStudy on Ivabradine for Preventing Heart Injury in Patients with Atherosclerosis Undergoing Noncardiac Surgery
PolandStudy on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain
PolandStudy on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine
PolandStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
PolandStudy on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
